Cargando…

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a common malignancy of the liver, whose heterogeneous incidence reflects genetic variations among individuals in the main risk factors. The receptor for advanced glycosylation endproducts (RAGE) is a multiligand receptor and known to be implicated in various pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Shih-Chi, Hsieh, Ming-Ju, Chou, Ying-Erh, Fan, Wen-Lang, Yeh, Chao-Bin, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602925/ https://www.ncbi.nlm.nih.gov/pubmed/26313784 http://dx.doi.org/10.1097/MD.0000000000001396

Ejemplares similares

Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Lin, Chien-Hua, et al.
Publicado: (2020)

Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Shiu, Jr-Shiang, et al.
Publicado: (2018)

Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2017)

ADAMTS14 Gene Polymorphism and Environmental Risk in the Development of Oral Cancer
por: Su, Shih-Chi, et al.
Publicado: (2016)

Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan
por: Huang, Wayne Shih-Wei, et al.
Publicado: (2017)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis
por: Xiao, Qi, et al.
Publicado: (2016)

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis
por: Wang, Binfeng, et al.
Publicado: (2021)

Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
por: Lee, Shou-Wu, et al.
Publicado: (2019)

Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development
por: Wang, Bin, et al.
Publicado: (2017)

Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression
por: Lau, Hon-Kit, et al.
Publicado: (2016)

Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma
por: Yang, Shun-Fa, et al.
Publicado: (2016)

Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
por: Lee, I-Cheng, et al.
Publicado: (2015)

Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report
por: Chen, Kuo-Hsin, et al.
Publicado: (2016)

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Pang, Qing, et al.
Publicado: (2015)

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
por: Huang, Hsien-Cheng, et al.
Publicado: (2022)

Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis
por: An, Pei-Pei, et al.
Publicado: (2020)

The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2021)

A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
por: Li, Qinghe, et al.
Publicado: (2021)

Spontaneous bacterial peritonitis caused by Campylobacter Coli in cirrhotic patient: A rare case report (CARE-compliant)
por: Wang, Cheng-Hui, et al.
Publicado: (2020)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network
por: Chang, Il-Chi, et al.
Publicado: (2016)

Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma
por: Wu, Dongbo, et al.
Publicado: (2017)

Hydrocele in recurrent acute pancreatitis caused by testicular venous obstruction: A case report of a rare complication (CARE-compliant)
por: Chang, Yin-Hsi, et al.
Publicado: (2020)

Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population
por: Li, Qing-Min, et al.
Publicado: (2017)

Increased risk of hepatocellular carcinoma in patients with traumatic liver injury: Real-world data from a nationwide population-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis
por: Wang, Kang, et al.
Publicado: (2016)

A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6
por: Hung, Hung-Hsu, et al.
Publicado: (2014)

Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort study
por: Chu, Chia-Sheng, et al.
Publicado: (2017)

Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening: A Validation Set From China
por: Jiang, Li, et al.
Publicado: (2015)

Association of hepatocellular carcinoma with thiazolidinediones use: A population-based case-control study
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma
por: Hsu, Wei-Fan, et al.
Publicado: (2021)

Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer
por: Liu, Tu-Chen, et al.
Publicado: (2016)

Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2017)

CD44 Gene Polymorphisms as a Risk Factor for Susceptibility and Their Effect on the Clinicopathological Characteristics of Lung Adenocarcinoma in Male Patients
por: Li, Ju-Pi, et al.
Publicado: (2020)

The impact of FOXP3 polymorphisms on oral cancer progression and clinicopathological characteristics
por: Chen, Ping-Ju, et al.
Publicado: (2023)

Global trends of targeted therapy for hepatocellular carcinoma: A bibliometric and visualized study from 2008 to 2022
por: Yang, Xuan-Ang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ss8jhfol1c4rni8hl5rkrem6b